(Q43253518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

positron emission tomography

11 February 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Ulrich Dührsen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Karl-Heinz Jöckel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Stefan Müller

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

1 reference

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1757-1760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

Revised response criteria for malignant lymphoma

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

Molecular diagnosis of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

Early therapy monitoring with FDG-PET in aggressive non-Hodgkin?s lymphoma and Hodgkin?s lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308031

10.3109/10428190903308031

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19863177%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference